Primary cutaneous T-cell lymphomas (CTCLs) are defined as lymphomas with a T-cell
phenotype that present in the skin without evidence of systemic or extracutaneous disease …

Cutaneous T-cell lymphoma (CTCL) is a heterogeneous disease group of unknown etiology
with a complex immunological background. As CTCL arises from T cells that have a vital role …

Background: Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative
disorder (SMPLPD) is a provisional entity within the 2016 World Health Organization …

Simple Summary While most patients with cutaneous T-cell lymphoma (CTCL) may be
diagnosed with early-stage disease, approximately 25–30% of those patients will …

Background The surface protein CD30 is a therapeutic target of monoclonal antibody
therapy. Knowledge of the frequency of CD30 expression and its prognostic relevance is …

Primary cutaneous T-cell lymphomas pose a diagnostic challenge for dermatopathologists,
hematopathologists, and general surgical pathologists. Recognition of gamma/delta …

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD)
was reclassified in 2016 as a rare benign entity with an excellent prognosis, yet its clinical …

Discussion PCGD-TCL is caused by clonal proliferation of γδ T-cell receptor-and cytotoxic
molecule-expressing T cells. 3 It is a rare subtype of CTCL and accounts for 1% of all …

Dermatologic disorders, affecting the integumentary system, involve diverse molecular
mechanisms such as cell proliferation, apoptosis, inflammation and immune responses …

Objective: Rare disease Background: Subcutaneous panniculitis-like T cell lymphoma and
primary cutaneous γδ T cell lymphoma are rare forms of non-Hodgkin lymphoma presenting …